Comparison of Breast Cancer 3-years Survival Rate Based on the Pathological Stages
Downloads
Methods: This study was conducted with a retrospective case control design using secondary data from Dr. Soetomo General Hospital's medical records. The technique used to take the samples was purposive sampling. The sample was 45 breast cancer patients in Dr. Soetomo General Hospital In January 2015, that able to be contacted again and had a medical record in the oncology center in Dr. Soetomo General Hospital Surabaya. The variables studied is breast cancer survival based on the pathological stages.
Results: Breast cancer patients at the stage of IIA have 100% 3-year survival rate, stage IIB by 83.3%, stage IIIA by 71.4%, stage IIIB by 53.8%, IIIC by 50%, and stage IV by 30%. With a comparison of the log-rank significance p = 0.104.
Conclusion: The survival rate of breast cancer patients is lower in line with the increasing pathological stage of breast cancer.
World Health Organization (WHO). Breast cancer: prevention and control. 2017.
Jemal A, Bray F, Center M M, Ferlay J, Ward E and Forman D. Global cancer statistics. CA : A Cancer Journal for Clinicians. 2011;61: 69–90, doi:10.3322/caac.20107.
Wahyuni A S, Sari A. Analisis Ketahanan Hidup 5 Tahun Pada Penderita Kanker Payudara Di Rumah Sakit Kanker Dharmais. 2008.
Fitzgibbons P L, Page D L, Weaver D, Thor A D, Allred D C, Clark G M, ... & Hayes D F. 2000, Prognostic factors in breast cancer: College of American Pathologists consensus statement 1999. Archives of pathology & laboratory medicine. 2000; 124(7), 966-978.
Swerdlow S H et al. World Health Organization Classification of Tumours. Lyon, France : IARC Press. 2008.
Elston C, Ellis I. Pathological Prognostic Factors in Breast Cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology. 1991;19(5):403-410.
Avis N, Crawford S, Manuel J. Quality of Life Among Younger Women With Breast Cancer. Journal of Clinical Oncology. 2005;23(15):3322-3330.
Anggorowati L. Faktor risiko kanker payudara wanita. Jurnal Kesehatan Masyarakat. 2013;8(2).
Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M et al. Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012. International Journal of Cancer. 2014;136(5):E359-E386.
Herasmoro AP. Gambaran Kejadian Metastasis Pada Pasien Kanker Payudara di Poli Onkologi Satu Atap (POSA) RSUD Dr. Soetomo Surabaya Periode Januari-Juni 2015. Universitas Airlangga. 2017.
Borst M J, Ingold J A. Metastatic patterns of invasive lobular versus invasive ductal carcinoma of the breast. Surgery. 1993;114(4), 637-642.
Augustya B. Profil Ekspresi Reseptor Estrogen dan Reseptor Progesteron Dengan Grading Histopatologis Pada Kanker Payudara Premenopause di RSUD Dr. Soetomo Surabaya. Universitas Airlangga. 2017.
Silcocks P. Staging and grading in breast cancer. British Journal of Cancer. 1983;47(5):733-734.
Herasmoro AP. Gambaran Kejadian Metastasis Pada Pasien Kanker Payudara di Poli Onkologi Satu Atap (POSA) RSUD Dr. Soetomo Surabaya Periode Januari-Juni 2015. Universitas Airlangga. 2017.
Stotter A, Reed M, Gray L, Moore N, Robinson T. Comprehensive Geriatric Assessment and predicted 3-year survival in treatment planning for frail patients with early breast cancer. British Journal of Surgery. 2015;102(5):525-533.
Chang H, Shi H, Wang B, Yeh S. Breast Cancer Incidence and Predictors of Surgical Outcome: a Nationwide Longitudinal Study in Taiwan. Clinical Oncology. 2017;29(6):362-369.
Desanti O. I., IM Sunarsih S. Persepsi Wanita Berisiko Kanker Payudara Tentang Pemeriksaan Payudara Sendiri Di Kota Semarang, Jawa Tengah. Berita Kedokteran Masyarakat. 2010;26(3), 152.
Bouchardy C, Fioretta G, Verkooijen H M, Vlastos G, Schaefer P, Delaloye J-F, ... Rapiti E. Recent increase of breast cancer incidence among women under the age of forty. British Journal of Cancer. 2007;96(11), 1743–1746.
Cubasch H, Dickens C, Joffe M, Duarte R, Murugan N, Tsai Chih M et al. Breast cancer survival in Soweto, Johannesburg, South Africa: A receptor-defined cohort of women diagnosed from 2009 to 11. Cancer Epidemiology. 2018;52:120-127.
1. The journal allows the author to hold the copyright of the article without restrictions.
2. The journal allows the author(s) to retain publishing rights without restrictions
3. The formal legal aspect of journal publication accessibility refers to Creative Commons Atribution-Share Alike 4.0 (CC BY-SA).
